Patients' and health-care professionals' perspectives on adverse drug reaction burden attributed to the use of biological DMARDs: a qualitative study.

Henrike J Westerink Leanne J Kosse Naomi T Jessurun Astrid van Tubergen Harald E Vonkeman Michael T NurmohamedBart J F van den BemtMarieke de Vries

Published in: Expert opinion on drug safety (2022)

Patients describe perceived ADR burden in both physical and psychological themes. The HCPs' perspective is comparable, but mostly focuses on psychological impact.

Keyphrases

end stage renal disease
adverse drug
healthcare
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
mental health
emergency department
rheumatoid arthritis
social support
systemic lupus erythematosus
social media
disease activity
sleep quality